News

Public · Published

UnitedHealth Group 3Q 2026: Revenue $112.7B, EPS $4.56— 10-Q Summary

UnitedHealth Group reported third-quarter 2026 revenue of $112.7 billion, down 0.4% year over year. Net income rose 75% to $4.11 billion and diluted earnings per share, or profit allocated to each share, increased 76.1% to $4.56. Lower medical costs and cost management supported 52% growth in operating earnings.

Published:

Updated:

What happened

UnitedHealth Group reported third-quarter 2026 revenue of $112.7 billion, down 0.4% year over year. Net income rose 75% to $4.11 billion and diluted earnings per share, or profit allocated to each share, increased 76.1% to $4.56. Lower medical costs and cost management supported 52% growth in operating earnings.

Confirmed

Global impact / market context

The results show sharply higher earnings despite slightly lower revenue, with lower medical costs and cost management providing support. Yet membership fell by 1.8 million and care activity, provider prices, and service intensity remained elevated, creating pressure that pricing, benefit design, and cost controls must address.

Analyst inference

UnitedHealth’s mixed results place earnings growth alongside contraction in some coverage areas: Medicare Advantage, Medicaid, and risk-based commercial membership declined, while fee-based commercial coverage grew. Optum revenue also fell 3%, although earnings improved across its segments, making the balance between cost control and business growth important.

Analyst inference

What to watch

  1. Watch whether the company’s pricing, benefit design, and cost controls contain medical-cost trends while care activity, provider prices, and service intensity remain elevated. Analyst inference
  2. Track whether membership declines in Medicare Advantage, Medicaid, and risk-based commercial plans continue, and whether fee-based commercial coverage growth offsets those losses. Analyst inference
  3. Watch for further detail on strategic asset sales and exits, which the company says advance its focus on core operations as some coverage participation contracts. Analyst inference

Evidence

  • Original source link unavailable